Tempus AI Stock Has Soared 108% Already in 2025; Is It a Buy Now?
Only time will tell if the market enthusiasm that drove artificial intelligence (AI) stocks higher in 2024 will extend through 2025. But one ticker that may be less recognizable among the AI crowd is certainly off to a roaring start since the ball fell on New Year's Eve.Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the company's use of AI to enhance physicians' abilities to diagnose patients (thereby improving patient care) enticing. The company does this with the help of its proprietary technology for developing what it characterizes as "one of the largest libraries of clinical and molecular oncology data in the world."Many potential investors, however, are likely left wondering if the stock has gotten ahead of itself and is better left alone right now, or if today is still a good time to click the buy button.Continue reading
Only time will tell if the market enthusiasm that drove artificial intelligence (AI) stocks higher in 2024 will extend through 2025. But one ticker that may be less recognizable among the AI crowd is certainly off to a roaring start since the ball fell on New Year's Eve.
Skyrocketing 108% since the start of 2025, Tempus AI (NASDAQ: TEM), a company applying AI solutions to healthcare, has seen its stock perform exceptionally well this year. Investors have found the company's use of AI to enhance physicians' abilities to diagnose patients (thereby improving patient care) enticing. The company does this with the help of its proprietary technology for developing what it characterizes as "one of the largest libraries of clinical and molecular oncology data in the world."
Many potential investors, however, are likely left wondering if the stock has gotten ahead of itself and is better left alone right now, or if today is still a good time to click the buy button.
